Supplementary Table 1 from Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

التفاصيل البيبلوغرافية
العنوان: Supplementary Table 1 from Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
المؤلفون: Amod A. Sarnaik, Shari Pilon-Thomas, Vernon K. Sondak, James J. Mulé, Jeffrey S. Weber, Nikhil I. Khushalani, Jamie K. Teer, Michael J. Schell, Marjorie Colón Colón, Carolyn J. Rich, Allison D. Richards, Alberto J. Martinez, Benjamin Schachner, Doris Wiener, Holly Branthoover, Luz Nagle, Patrick Innamarato, Jamie Blauvelt, Matthew S. Beatty, Amy M. Hall, Cheryl A. Cox, John E. Mullinax, MacLean S. Hall
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Table 1 shows the distribution of Grade 3 and 4 non-hematologic adverse events reported in this study.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5a871859561fb70cfe92dcdaf6ddff
https://doi.org/10.1158/1078-0432.22488842
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....cb5a871859561fb70cfe92dcdaf6ddff
قاعدة البيانات: OpenAIRE